Investment Summary |
|
|---|---|
| Date | 2013-06-25 |
| Target | MDxHealth |
| Sector | Life Science |
| Investor(s) | Biovest |
| Sellers(s) | Andera Partners |
| Deal Type | Stake Purchase |
SEARCH BY
Biovest is an investment company that mainly focuses on life science. Biovest was founded in 1996 and is based in Gent, Belgium.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: Belgium M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 42 |
| Sector: Life Science M&A | 1 of 8 |
| Type: Stake Purchase M&A Deals | 1 of 4 |
| Country: Belgium M&A | 2 of 3 |
| Year: 2013 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-10 |
Offibat
Crosne, France Offibat provides maintenance of electrical installations in social housing. Offibat offers a wide range of services for the residential sector in Paris area through 4 subsidiaries : Cide-Elec (electricity and home refurbishment), TSO Reali (locksmithing and metal structure), RSCP (heating, ventilation, and air conditioning) and COPCIE (roof covering, plumbing, watertightness). Offibat is based in Crosne, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-26 |
Complix
Ghent, Belgium Complix is focused on the discovery and development of alpha bodies, a novel class of biopharmaceuticals that, due to their unique structural and functional properties, are particularly suited to address disease targets that are difficult to reach with antibodies or other types of therapeutic protein scaffolds. Complix was founded in 2008 and is based in Ghent, Belguim. |
Buy | - |
